PG

NYSE

PROCTER & GAMBLE Co

Latest disclosureOctober 6, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 18 sales

Price by TradingView

Insider transactions 122

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $1.24M by 3 insiders.

Showing the first 6 of 18 trades on this page.

Sale disclosed

Andre Schulten

Chief Financial Officer

Common Stock

Reported value: $568.86K
Reported price: $145.34 / share

Sale disclosed

Paul Gama

CEO- Health Care

Common Stock

Reported value: $323.38K
Reported price: $145.34 / share

Sale disclosed

Susan Street Whaley

Chief Legal Officer & Secy

Common Stock

Reported value: $344.31K
Reported price: $145.34 / share

Sale disclosedAmended filing

Moses Victor Javier Aguilar

Chf Rsch, Dev & Innov Officer

Filing error, value unverified

The filed price or transaction value needs verification before it can be used in totals or buying signals.

Raw filed price per unit: $143.79
Raw implied value: $438,990.87
Verified price: —
Verified value: —
Confidence: low
Validation findings: amendment requires reconciliation · price missing

Original transaction filing ↗

Common Stock

Reported value: —
Reported price: —

Understand this price

Filing error, value unverified. The filed amounts are preserved for review and excluded from buying signals and transaction totals until verified.

Sale disclosed

Matthew W. Janzaruk

SVP - Chief Accounting Officer

Common Stock

Reported value: $52.14K
Reported price: $145.24 / share

Sale disclosed

Moses Victor Javier Aguilar

Chf Rsch, Dev & Innov Officer

Common Stock

Reported value: $438.99K
Reported price: $143.79 / share

Sale disclosed

El Hak Hesham Abd

CEO-Baby and Feminine Care

Common Stock

Reported value: $278.38K
Reported price: $143.79 / share

Sale disclosed

Sundar G. Raman

CEO-Fabric Home & Habitat Care

Common Stock

Reported value: $491.27K
Reported price: $143.02 / share

Sale disclosed

de Azevedo Juliana Monteiro Santos

CEO - Grooming

Common Stock

Reported value: $340.49K
Reported price: $143.79 / share

Sale disclosed

Matthew W. Janzaruk

SVP - Chief Accounting Officer

Common Stock

Reported value: $22.43K
Reported price: $143.79 / share

Sale disclosed

Andre Schulten

Chief Financial Officer

Common Stock

Reported value: $776.75K
Reported price: $143.79 / share

Sale disclosed

Freddy P. Bharucha

CEO - Beauty

Common Stock

Reported value: $35.37K
Reported price: $143.79 / share

Sale disclosed

Balaji Purushothaman

Chief Human Resources Officer

Common Stock

Reported value: $290.31K
Reported price: $143.79 / share

Sale disclosed

Shailesh Jejurikar

Chairman, President and CEO

Common Stock

Reported value: $888.05K
Reported price: $143.79 / share

Sale disclosed

Paul Gama

CEO- Health Care

Common Stock

Reported value: $488.31K
Reported price: $143.79 / share

Sale disclosed

Susan Street Whaley

Chief Legal Officer & Secy

Common Stock

Reported value: $321.8K
Reported price: $143.79 / share

Sale disclosed

Marc S. Pritchard

Chief Brand Officer

Common Stock

Reported value: $579.47K
Reported price: $143.79 / share

Sale disclosed

Susan Street Whaley

Chief Legal Officer & Secy

Common Stock

Reported value: $1.24M
Reported price: $144.00 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Chief Financial Officer	Common StockSale	3,914$145.34 / share	$568.86K	Oct 5Filed Oct 6 · 1d later	SEC filing
CEO- Health Care	Common StockSale	2,225$145.34 / share	$323.38K	Oct 5Filed Oct 6 · 1d later	SEC filing
Chief Legal Officer & Secy	Common StockSale	2,369$145.34 / share	$344.31K	Oct 5Filed Oct 6 · 1d later	SEC filing
Chf Rsch, Dev & Innov Officer Filing error, value unverified The filed price or transaction value needs verification before it can be used in totals or buying signals. Raw filed price per unit $143.79 Raw implied value $438,990.87 Verified price — Verified value — Confidence low Validation findings amendment requires reconciliation · price missing Original transaction filing ↗	Common StockSale	3,053—	—	Aug 20Filed Aug 27 · 7d later	SEC filing
SVP - Chief Accounting Officer	Common StockSale	359$145.24 / share	$52.14K	Aug 24Filed Aug 24 · 0d later	SEC filing
Chf Rsch, Dev & Innov Officer	Common StockSale	3,053$143.79 / share	$438.99K	Aug 19Filed Aug 24 · 5d later	SEC filing
CEO-Baby and Feminine Care	Common StockSale	1,936$143.79 / share	$278.38K	Aug 20Filed Aug 24 · 4d later	SEC filing
CEO-Fabric Home & Habitat Care	Common StockSale	3,435$143.02 / share	$491.27K	Aug 21Filed Aug 24 · 3d later	SEC filing
CEO - Grooming	Common StockSale	2,368$143.79 / share	$340.49K	Aug 20Filed Aug 24 · 4d later	SEC filing
SVP - Chief Accounting Officer	Common StockSale	156$143.79 / share	$22.43K	Aug 20Filed Aug 24 · 4d later	SEC filing
Chief Financial Officer	Common StockSale	5,402$143.79 / share	$776.75K	Aug 20Filed Aug 24 · 4d later	SEC filing
CEO - Beauty	Common StockSale	246$143.79 / share	$35.37K	Aug 20Filed Aug 24 · 4d later	SEC filing
Chief Human Resources Officer	Common StockSale	2,019$143.79 / share	$290.31K	Aug 20Filed Aug 24 · 4d later	SEC filing
Chairman, President and CEO	Common StockSale	6,176$143.79 / share	$888.05K	Aug 20Filed Aug 24 · 4d later	SEC filing
CEO- Health Care	Common StockSale	3,396$143.79 / share	$488.31K	Aug 20Filed Aug 24 · 4d later	SEC filing
Chief Legal Officer & Secy	Common StockSale	2,238$143.79 / share	$321.8K	Aug 20Filed Aug 24 · 4d later	SEC filing
Chief Brand Officer	Common StockSale	4,030$143.79 / share	$579.47K	Aug 20Filed Aug 24 · 4d later	SEC filing
Chief Legal Officer & Secy	Common StockSale	8,644$144.00 / share	$1.24M	Aug 18Filed Aug 20 · 2d later	SEC filing

Congress transactions 36

All Congress filings

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 8, 2026

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

Lloyd DoggettReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 17, 2026

Sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: August 24, 2026

Sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 5, 2026

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 11, 2026

Sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a sale for the member.

Richard Dean Dr McCormick official portrait

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 30, 2026

Full sale disclosedAmended report

Procter & Gamble Company (The) Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 3, 2024

Full sale disclosed

Procter & Gamble Company (The) Common Stock · Stock

The filing reports a full sale for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Full sale disclosed

Procter & Gamble Company (The) Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: June 8, 2026

Sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a sale for a spouse.

Richard W. AllenReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: April 16, 2026

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

Lloyd DoggettReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 15, 2026

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 27, 2026

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 27, 2026

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 2, 2026

Partial sale disclosed

Procter & Gamble Company (The) Common Stock · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 26, 2026

Sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 26, 2026

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

Lloyd DoggettReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 17, 2026

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 9, 2026

Partial sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 30, 2026

Sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 29, 2026

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 9, 2026

Sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 18, 2025

Purchase disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a purchase for the member.

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 16, 2025

Partial sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 24, 2025

Sale disclosed

Procter & Gamble Company (PG) · Stock

The filing reports a sale for a spouse.

Ed CaseReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 1, 2025

Showing the latest 25 of 36 disclosed trades. Show all 36 trades

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000080424
Latest public acceptance: Oct 6, 2026, 08:21 PM UTC
Score calculated: Oct 8, 2026, 12:03 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

Chief Financial Officer

Common StockSale

3,914$145.34 / share

$568.86K

Oct 5Filed Oct 6 · 1d later

SEC filing

CEO- Health Care

Common StockSale

2,225$145.34 / share

$323.38K

Oct 5Filed Oct 6 · 1d later

SEC filing

Chief Legal Officer & Secy

Common StockSale

2,369$145.34 / share

$344.31K

Oct 5Filed Oct 6 · 1d later

SEC filing

Chf Rsch, Dev & Innov Officer

Filing error, value unverified

The filed price or transaction value needs verification before it can be used in totals or buying signals.

Raw filed price per unit: $143.79
Raw implied value: $438,990.87
Verified price: —
Verified value: —
Confidence: low
Validation findings: amendment requires reconciliation · price missing

Original transaction filing ↗

Common StockSale

3,053—

—

Aug 20Filed Aug 27 · 7d later

SEC filing

SVP - Chief Accounting Officer

Common StockSale

359$145.24 / share

$52.14K

Aug 24Filed Aug 24 · 0d later

SEC filing

Chf Rsch, Dev & Innov Officer

Common StockSale

3,053$143.79 / share

$438.99K

Aug 19Filed Aug 24 · 5d later

SEC filing

CEO-Baby and Feminine Care

Common StockSale

1,936$143.79 / share

$278.38K

Aug 20Filed Aug 24 · 4d later

SEC filing

CEO-Fabric Home & Habitat Care

Common StockSale

3,435$143.02 / share

$491.27K

Aug 21Filed Aug 24 · 3d later

SEC filing

CEO - Grooming

Common StockSale

2,368$143.79 / share

$340.49K

Aug 20Filed Aug 24 · 4d later

SEC filing

SVP - Chief Accounting Officer

Common StockSale

156$143.79 / share

$22.43K

Aug 20Filed Aug 24 · 4d later

SEC filing

Chief Financial Officer

Common StockSale

5,402$143.79 / share

$776.75K

Aug 20Filed Aug 24 · 4d later

SEC filing

CEO - Beauty

Common StockSale

246$143.79 / share

$35.37K

Aug 20Filed Aug 24 · 4d later

SEC filing

Chief Human Resources Officer

Common StockSale

2,019$143.79 / share

$290.31K

Aug 20Filed Aug 24 · 4d later

SEC filing

Chairman, President and CEO

Common StockSale

6,176$143.79 / share

$888.05K

Aug 20Filed Aug 24 · 4d later

SEC filing

CEO- Health Care

Common StockSale

3,396$143.79 / share

$488.31K

Aug 20Filed Aug 24 · 4d later

SEC filing

Chief Legal Officer & Secy

Common StockSale

2,238$143.79 / share

$321.8K

Aug 20Filed Aug 24 · 4d later

SEC filing

Chief Brand Officer

Common StockSale

4,030$143.79 / share

$579.47K

Aug 20Filed Aug 24 · 4d later

SEC filing

Chief Legal Officer & Secy

Common StockSale

8,644$144.00 / share

$1.24M

Aug 18Filed Aug 20 · 2d later

SEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000080424
Latest public acceptance: Oct 6, 2026, 08:21 PM UTC
Score calculated: Oct 8, 2026, 12:03 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.